JOSIE BAZEMORE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health BOSTON, MA NPI 1871978502
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health MA BeiGene USA, Inc. All categories
General Payments — all program years on this page
$17,439.74
- Category: General Payments
- Program years: PY2021–2024
- Record count: 53
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $6,936.27 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,217.50 | 4 |
| Food and Beverage | $718.77 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $4,480.00 | 3 |
| Acerta Pharma LLC | $1,305.00 | 1 |
| ABBVIE INC. | $919.91 | 4 |
| Genmab U.S., Inc. | $121.86 | 1 |
| Lilly USA, LLC | $109.50 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105336418 | AstraZeneca Pharmaceuticals LP | $1,305.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1106498693 | ABBVIE INC. | $562.50 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1106498695 | ABBVIE INC. | $124.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106498697 | ABBVIE INC. | $107.50 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106498699 | ABBVIE INC. | $124.99 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120844433 | BeiGene USA, Inc. | $3,150.00 | 12/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1120844437 | BeiGene USA, Inc. | $1,200.00 | 10/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1120844440 | BeiGene USA, Inc. | $130.00 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126836612 | Genmab U.S., Inc. | $121.86 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135647001 | Lilly USA, LLC | $109.50 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.